Tara O. Henderson to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Tara O. Henderson has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.146
-
Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study. J Patient Rep Outcomes. 2023 Nov 10; 7(1):113.
Score: 0.057
-
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma. J Natl Cancer Inst. 2021 03 01; 113(3):282-291.
Score: 0.047
-
Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study. J Clin Oncol. 2019 11 10; 37(32):3009-3017.
Score: 0.042